Legal status · United States
Is Tirzepatide with B12 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Tirzepatide with B12 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Tirzepatide with B12 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Compounded on prescription. Tirzepatide itself is approved; the fixed combination with B12 is not, and is not reviewed by FDA. |
| FDA approval status | Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality. FDA has published standing concerns about unapproved GLP-1 products sold for weight loss. |
| Human studies cited | 2 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Tirzepatide with B12 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Tirzepatide with B12 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Tirzepatide with B12 is
The one blend in this database with a published chemical reason not to mix it. Laboratory testing of compounded tirzepatide plus B12 products from multiple sources found a widespread, previously unidentified impurity formed by a reaction between the peptide and certain B12 analogues. The testing was done by the branded manufacturer, which is a disclosed conflict, and it is the only published chemistry on these premixes.
Most pages in this section have to say that nobody has looked. This one is different: somebody looked, and they found something.
Mechanism: Tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces appetite and slows gastric emptying. Cyanocobalamin is a B12 form used to correct deficiency.
Regulatory history: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality. FDA has published standing concerns about unapproved GLP-1 products sold for weight loss.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Tirzepatide with B12 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Tirzepatide with B12 in other countries
Frequently asked questions
Is Tirzepatide with B12 legal in the United States?
No. Tirzepatide with B12 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Compounded on prescription. Tirzepatide itself is approved; the fixed combination with B12 is not, and is not reviewed by FDA.
Can I buy Tirzepatide with B12 in the United States?
No approved product exists to buy. In the United States Tirzepatide with B12 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Compounded on prescription. Tirzepatide itself is approved; the fixed combination with B12 is not, and is not reviewed by FDA.
Is Tirzepatide with B12 FDA approved?
No. FDA status: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality. FDA has published standing concerns about unapproved GLP-1 products sold for weight loss.. Current US classification: "Not approved; research use only". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Tirzepatide with B12 live on its compound profile.
Tirzepatide with B12 profileThis page is general information about the regulatory status of Tirzepatide with B12 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.